Skip to content

Efficacy of Repetitive Transcranial Magnetic Stimulation for the Prevention of Postoperative Delirium in Elderly Patients Undergoing Total Hip Arthroplasty

Efficacy of Repetitive Transcranial Magnetic Stimulation for the Prevention of Postoperative Delirium in Elderly Patients Undergoing Total Hip Arthroplasty

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600121503
Enrollment
Unknown
Registered
2026-03-31
Start date
2026-03-31
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative delirium

Interventions

TMS group:The patient received a 20-minute rTMS treatment once the day before surgery and once after extubation in the PACU.
control group:The patient undergoes the same RMT measurement, with a similar coil position, but no active stimulation is performed.

Sponsors

Xuzhou Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age 65 years or older; 2. Duration of THA surgery between 60 to 180 minutes; 3. ASA classification I-III; 4. Education level of elementary school or above; 5. Montreal Cognitive Assessment score =26 points (add 1 point for those with =12 years of education); 6. Normal speech and hearing, able to cooperate with rehabilitation assessment and treatment.

Exclusion criteria

Exclusion criteria: 1. Known drug allergies, severe cardiovascular diseases, or liver and kidney dysfunction; 2. Use of sedative-hypnotics or drugs with anticholinergic effects that cannot be discontinued for at least four weeks prior to baseline; 3. rTMS contraindications: such as a history of epilepsy, cochlear implants, metal implants in the head, or pacemakers; 4. Currently participating in other clinical trials; 5. The participant or their legal representative is unable or unwilling to provide written informed consent.

Design outcomes

Primary

MeasureTime frame
Incidence of postoperative delirium within 3 days after surgery;

Secondary

MeasureTime frame
subtypes of delirium;side effects;Pain score NRS 1-3 days post-surgery;Anxiety score (SAS) and depression score (SDS) one day after surgery;

Countries

China

Contacts

Public ContactLiwei Wang

Xuzhou Central Hospital

18952170255@189.cn+86 189 5217 0255

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026